Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Puneet Singh Cheema"'
Autor:
Brad S. Kahl, Julie E. Chang, Terrence P. Cescon, Jane N. Winter, Timothy E. O'Brien, Philip A. Dy, Puneet Singh Cheema, Stephen M. Ansell, Erik A. Ranheim, Andrew Quon, Thomas E. Witzig, Randy D. Gascoyne, Ranjana H. Advani, Thomas M. Habermann, Fangxin Hong, Andrew M. Evens
Supplemental Tables 1-9
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0a1037779ccf654dcbeee0a061dde62
https://doi.org/10.1158/1078-0432.22477346
https://doi.org/10.1158/1078-0432.22477346
Autor:
Brad S. Kahl, Julie E. Chang, Terrence P. Cescon, Jane N. Winter, Timothy E. O'Brien, Philip A. Dy, Puneet Singh Cheema, Stephen M. Ansell, Erik A. Ranheim, Andrew Quon, Thomas E. Witzig, Randy D. Gascoyne, Ranjana H. Advani, Thomas M. Habermann, Fangxin Hong, Andrew M. Evens
Purpose:We sought to improve upon frontline bendamustine/rituximab (BR) induction therapy followed by rituximab maintenance in untreated high-risk follicular lymphoma (FL).Patients and Methods:Patients were randomized to BR induction followed by 2-ye
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::360ee251e8485fcb00e39c958d72ee2f
https://doi.org/10.1158/1078-0432.c.6529628
https://doi.org/10.1158/1078-0432.c.6529628
Autor:
Andrew M. Evens, Andrew Quon, Brad S. Kahl, Thomas M. Habermann, Randy D. Gascoyne, Terrence P. Cescon, Jane N. Winter, Puneet Singh Cheema, Stephen M. Ansell, Timothy E. O'Brien, Philip A. Dy, Thomas E. Witzig, Julie E. Chang, Ranjana H. Advani, Fangxin Hong, Erik A. Ranheim
Publikováno v:
Clin Cancer Res
Purpose: We sought to improve upon frontline bendamustine/rituximab (BR) induction therapy followed by rituximab maintenance in untreated high-risk follicular lymphoma (FL). Patients and Methods: Patients were randomized to BR induction followed by 2